Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Unidades: FM, ICB
Subjects: FARMACOLOGIA, IMUNOLOGIA, LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, PROTO-ONCOGENES, FOSFOPROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, SULFONAMIDAS, FOSFATOS DE AÇÚCAR
ABNT
QUEIROZ, Gustavo Nery de et al. Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, v. 1872, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2025.168065. Acesso em: 03 jan. 2026.APA
Queiroz, G. N. de, Lima, K., Cipelli, M., Tomaz, V., Cortez, L. G. F., Silva, M. de F. B., et al. (2025). Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872, 12 . doi:10.1016/j.bbadis.2025.168065NLM
Queiroz GN de, Lima K, Cipelli M, Tomaz V, Cortez LGF, Silva M de FB, Guedes RLM, Campregher PV, Rego EM, Câmara NOS, Costa-Lotufo LV, Machado Neto JA. Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025 ; 1872 12 .[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.bbadis.2025.168065Vancouver
Queiroz GN de, Lima K, Cipelli M, Tomaz V, Cortez LGF, Silva M de FB, Guedes RLM, Campregher PV, Rego EM, Câmara NOS, Costa-Lotufo LV, Machado Neto JA. Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia [Internet]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025 ; 1872 12 .[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.bbadis.2025.168065
